Vijay Kumar Panthi | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Engineer

Mr. Vijay Kumar Panthi | Medicine and Health Sciences | Best Researcher Award

PhD Candidate, Queensland University of Technology, Australia

Vijay Kumar Panthi is a seasoned professional in Pharmaceutics with a focus on drug delivery and formulation. He holds a Master’s degree in Pharmacy (Pharmaceutics) from Mokpo National University, South Korea, and a Bachelor’s degree in Pharmacy from Tribhuvan University, Nepal. With extensive experience in formulation, research, and development, he has worked with several prominent pharmaceutical companies, including Royal Sasa Nepal Pharmaceuticals and Corel Pharmaceuticals. His expertise spans across nanoformulations, drug delivery systems, and formulation development for anticancer and anti-aging treatments. He has also contributed to several publications and conference posters, particularly in the field of nanomedicine, wound healing, and oral drug bioavailability. His research interests center around enhancing drug solubility and permeability, particularly for anticancer and diabetes treatments. He is a registered pharmacist with the Pharmacy Council of Nepal and actively engages in clinical pharmacy training and regulatory affairs.

Profile

Education

Vijay Kumar Panthi completed his Master’s in Pharmacy (Pharmaceutics) from Mokpo National University, South Korea, between 2017-2019. This advanced program deepened his knowledge of drug formulation, nanoformulations, and drug delivery systems. He earned his Bachelor’s degree in Pharmacy from Tribhuvan University, Nepal, at Sunsari Technical College, Dharan, between 2010 and 2014. Additionally, he completed Intermediate studies in Pharmacy at the Nepal Institute of Medical Science and Technology (NIMST), Kathmandu. Before that, he graduated from Mukti Higher Secondary School, Pyuthan, Nepal, in 2005. His academic journey has provided him with a solid foundation in pharmaceutical sciences and research, focusing on developing innovative solutions to improve drug efficacy and bioavailability, particularly in cancer and diabetes therapies.

Experience

Vijay Kumar Panthi has over 10 years of experience in the pharmaceutical industry, spanning formulation development, research, and regulatory affairs. He currently serves as the Manager of Formulation, Research, and Development (FR&D) at Royal Sasa Nepal Pharmaceuticals. Prior to this, he held the same position at Corel Pharmaceuticals Pvt. Ltd., where he developed and tested various drug formulations. His experience also includes conducting formulation and development research at Mokpo National University, South Korea, between 2017 and 2019. Additionally, he worked at Asian Pharmaceuticals Pvt. Ltd., where he contributed to GMP-certified projects, regulatory affairs, and validation processes. He has also participated in industrial training at companies like Everest Pharmaceuticals, Nepal, and Zydus Healthcare, India, which further honed his practical knowledge. Vijay’s diverse experience across multiple pharmaceutical functions highlights his expertise in drug formulation and development, particularly for anticancer and anti-aging applications.

Research Focus

Vijay Kumar Panthi’s primary research interests lie in the formulation of drug delivery systems, particularly for anticancer and diabetes treatments. His work focuses on enhancing the solubility, permeability, and bioavailability of active pharmaceutical ingredients (APIs), particularly those with limited oral bioavailability. In his Master’s thesis, he worked on the co-delivery system of pemetrexed and quercetin via multiple nanoemulsions to improve oral bioavailability and anticancer efficacy. His interest in nanoformulations extends to other therapeutic areas such as wound healing and anti-aging. By utilizing nanoemulsions, liposomes, and hydrogels, Vijay aims to develop novel drug delivery systems that improve the therapeutic outcomes of drugs for various diseases, especially chronic conditions like cancer and diabetes. His research on the formulation of anti-acne treatments and serine protease formulations for inflammation also demonstrates his versatility and commitment to improving patient care through scientific advancements.

Publication Top Notes

  1. Characterization and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin 📚💊
  2. Preparation, Characterization, and Biological Activities of Topical Anti-Aging Ingredients in a Citrus junos Callus Extract 🍊💆‍♂️
  3. Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation 🧴🔬
  4. Enhanced Oral Absorption of Pemetrexed by Ion-Pairing Complex Formation with Deoxycholic Acid Derivative and Multiple Nanoemulsion Formulations 💊🧪
  5. Formulation and Development of Serratiopeptidase Enteric Coated Tablets and Analytical Method Validation by UV Spectroscopy 🧫🔬
  6. A Validated RP-HPLC Method for Simultaneous Determination of Cefixime and Clavulanic Acid Powder in Pediatric Oral Suspension 🧪👶
  7. Preparation and Characterization of Callus Extract From Pyrus pyrifolia and Investigation of Its Effects on Skin Regeneration 🍐🧴
  8. Formulation and Development of Water-in-Oil Emulsion-Based Luliconazole Cream: In Vitro Characterization and Analytical Method Validation by RP-HPLC 🧴🔬

 

 

Friedrich Paulsen | Medicine | Excellence in Research

Published on by Popular Engineer

Mr. Friedrich Paulsen | Medicine | Excellence in Research

Head of Department of Functional and Clinical Anatomy, Friedrich-Alexander-University Erlangen-Nürnberg, Germany

Professor Friedrich Paulsen is a distinguished anatomist, specializing in gross anatomy and histology. He serves as the Chair of the Institute of Functional and Clinical Anatomy at Friedrich Alexander University (FAU) Erlangen-Nürnberg, Germany. With a wealth of experience in both teaching and research, Dr. Paulsen is a renowned figure in the field of anatomy and has contributed extensively to textbooks such as the SOBOTTA Atlas and SOBOTTA Textbook of Human Anatomy. He has held key positions, including Secretary General of the International Federation of Associations of Anatomists (2009–2019) and president of the European Federation of Experimental Morphology (2021-2023). His research interests focus on the head and neck region, specifically the ocular surface and tear film, making him one of the top 2% most cited scientists in the world in his field.

Profile

Education

Professor Friedrich Paulsen earned his MD from CAU Kiel in Germany, where he began his journey into the world of anatomy and histology. He later expanded his research capabilities through a position as a researcher at the University of Bristol, UK. Over the years, Dr. Paulsen’s educational pursuits and scientific contributions have been complemented by his leadership in the academic field. From 2004 to 2010, he was a full professor of anatomy at MLU Halle-Wittenberg, before taking the Chair at FAU Erlangen-Nürnberg. Throughout his career, Dr. Paulsen’s commitment to academic excellence has been recognized with multiple honorary doctorates, including from Carol Davila University (2022) and Grigore T. Popa University (2023). His comprehensive educational background, from his early medical training to his leadership in anatomical education, has allowed him to shape future generations of scientists and medical professionals.

Experience

Professor Friedrich Paulsen has extensive experience in both research and academic leadership. Since 2006, he has been an active member of the German Anatomische Gesellschaft, serving as secretary and board member. His leadership extended internationally as he was the Secretary General of the International Federation of Associations of Anatomists from 2009 to 2019. From 2016 to 2022, he held the position of Vice President at Friedrich Alexander University (FAU), overseeing a student body of over 41,000. Throughout his career, Dr. Paulsen has also served as editor-in-chief of the Annals of Anatomy and as section editor for numerous scientific journals. His academic and professional expertise has earned him significant recognition in the anatomical community, further reinforcing his reputation as a global leader in the field of anatomy. He has contributed to over 400 peer-reviewed articles and book chapters, solidifying his legacy as a pioneer in clinical and functional anatomy.

Research Focus

Professor Friedrich Paulsen’s research primarily focuses on the functional and clinical anatomy of the head and neck region, with particular emphasis on the ocular surface, tear film, and draining lacrimal system. His work in ocular immunology has provided important insights into the immune functions of the eye and its surrounding structures. Through his research, Dr. Paulsen has contributed significantly to understanding the mechanical properties of human tissues, particularly the brain and synovial joints, which has important implications for medical treatments and interventions. His research is not confined to anatomy alone; he has also worked on clinical applications related to ophthalmology, cancer biology, and antimicrobial peptides. As one of the most highly cited scientists in the field, his ongoing work continues to bridge the gap between theoretical anatomical knowledge and its practical application in medical practice.

Publication Top Notes

  • Mechanical characterization of human brain tissue 🧠🔬 (Cited 647 times, 2017)
  • Locally renewing resident synovial macrophages provide a protective barrier for the joint 🦴💪 (Cited 509 times, 2019)
  • Acknowledging the use of human cadaveric tissues in research papers: Recommendations from anatomical journal editors 💀📑 (Cited 499 times, 2021)
  • The dissection course–necessary and indispensable for teaching anatomy to medical students 📚🦷 (Cited 415 times, 2008)
  • The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid–protein interactions in health and disease 👁️💧 (Cited 397 times, 2011)
  • Sobotta Atlas of Anatomy, Vol. 2, English/Latin: Internal Organs 📖🫀 (Cited 326 times, 2023)
  • Curving and looping of the internal carotid artery in relation to the pharynx: frequency, embryology and clinical implications 🏥🩺 (Cited 307 times, 2000)
  • Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines 💉⚔️ (Cited 283 times, 2006)
  • The legal and ethical framework governing Body Donation in Europe-A review of current practice and recommendations for good practice ⚖️📝 (Cited 263 times, 2008)
  • IgA subclasses have different effector functions associated with distinct glycosylation profiles 🧬💉 (Cited 257 times, 2020)
  • Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina 👀🐭 (Cited 251 times, 2007)
  • Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells 🦠🔬 (Cited 248 times, 2008)
  • Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid 💧👁️ (Cited 233 times, 2013)

 

 

 

Lars Blønd | Orthopedic Surgery | Best Researcher Award

Published on by Popular EngineerLeave a Comment on Lars Blønd | Orthopedic Surgery | Best Researcher Award

Dr. Lars Blønd | Orthopedic Surgery | Best Researcher Award

Senior Surgeon, The Zealand University of Koege and Aleris-Hamlet Hospitals, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon, born in 1961 in Denmark, with specialized expertise in knee and shoulder arthroscopy. He earned his medical degree from the University of Copenhagen in 1991 and became a specialist in orthopedic surgery in 2001. Dr. Blønd is renowned for developing the innovative “Arthroscopic Deepening Trochleoplasty” for patellofemoral surgeries. He is currently practicing at The Zealand University Hospital of Koege and Aleris Hospitals while also contributing to the Danish Patient Safety Authority and Arthrex as a consultant. His career has spanned various roles, including chief surgeon at multiple university hospitals and sports physician for the Danish Superliga soccer team, HB Koege FC. Dr. Blønd’s work has gained international recognition in the field of orthopedic surgery, and he continues to be actively involved in research, contributing to the advancement of orthopedic treatments worldwide. 🏥👨‍⚕️💼

Profile

Education

Dr. Lars Blønd’s education began with his graduation from Gymnasium in 1981, followed by military service in the Danish Navy in 1982. He then pursued his medical studies at the University of Copenhagen (Cph), where he matriculated in 1984 and graduated in 1991. After completing his medical degree, Dr. Blønd specialized in orthopedic surgery, obtaining his certification in June 2001. He also earned a Certificate in Sports Medicine in 2003, further enhancing his expertise in treating athletes and individuals with sports-related injuries. Throughout his career, Dr. Blønd participated in postgraduate training across eight hospitals from 1991 to 2002, which allowed him to develop a comprehensive understanding of orthopedic practices. His diverse educational background and commitment to continuous learning have enabled him to push the boundaries of orthopedic surgery and contribute significantly to the field of sports medicine. 🎓📚🏅

Experience

Dr. Lars Blønd has over three decades of experience in orthopedic surgery, focusing primarily on knee and shoulder arthroscopy. Since 2013, he has worked as a senior surgeon at both The Zealand University Hospital of Koege and Aleris Hospitals, where he continues to provide expert care to patients. In addition to his clinical work, Dr. Blønd holds positions as a consultant for the Danish Patient Safety Authority and as an instructor for Arthrex. Previously, Dr. Blønd served as Chief Surgeon at GHP (2008-2013), Herlev University Hospital (2006-2008), and Gentofte University Hospital (2004-2006). He has also worked part-time as a consultant at Parkens Private Hospital and Nygart Private Hospital and served as a team physician for the Superliga soccer team, HB Koege FC. His extensive clinical experience has shaped his reputation as a leading expert in patellofemoral surgeries and sports medicine. 👨‍⚕️🏥⚽

Research Focus

Dr. Lars Blønd’s research is focused on advancing orthopedic treatments, particularly in the realm of knee and shoulder surgeries. His primary area of expertise lies in patellofemoral disorders, specifically patellar instability, pain syndromes, and dislocations. Dr. Blønd is the inventor of the “Arthroscopic Deepening Trochleoplasty,” a groundbreaking surgical technique designed to address patellofemoral problems. His research also extends to the use of arthroscopy for treating osteoarthritis and injuries related to sports. He has published multiple influential studies on the effectiveness of various treatments for patellar dislocations, patellofemoral pain syndrome, and the use of autologous adipose tissue in osteoarthritis treatment. Dr. Blønd is also dedicated to exploring innovative surgical approaches and the biomechanics of knee and shoulder joint function. His work is widely cited and has contributed to improving patient outcomes in orthopedic surgeries globally. 📊🔬🦵

Publication Top Notes

  1. Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes 📚🦵
  2. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty 🩸💉
  3. High incidence of acute and recurrent patellar dislocations: a retrospective nationwide epidemiological study 🦵📈
  4. Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament 🏥🔬
  5. Quality assessment of radiological measurements of trochlear dysplasia; a literature review 📐📊
  6. The arthroscopic deepening trochleoplasty 🦵🔧
  7. Treatment of osteoarthritis with autologous and microfragmented adipose tissue 🦵💉
  8. Exsanguination of the upper limb in healthy young volunteers 🦵🤕
  9. Arthroscopic treatment for snapping scapula: a prospective case series 🦵⚙️
  10. Translation, adaptation and measurement properties of an electronic version of the Danish WOSI 🖥️📊

 

 

Jorge Amador Berlanga-Acosta | Medicine and Health Sciences | Best Researcher Award

Published on by Popular EngineerLeave a Comment on Jorge Amador Berlanga-Acosta | Medicine and Health Sciences | Best Researcher Award

Prof Dr Jorge Amador Berlanga-Acosta | Medicine and Health Sciences | Best Researcher Award

Research project leader, Center for Genetic Engineering and Biotechnology, Cuba

Dr. Jorge Amador Berlanga Acosta is a distinguished Cuban veterinary medicine and pharmaceutical scientist, born on October 11, 1962, in Bayamo, Granma, Cuba. With a career spanning over three decades, he specializes in the pharmacological applications of Epidermal Growth Factor (EGF) for wound healing and diabetic foot ulcers. He holds several prestigious titles, including Member of Honor of the Cuban National Academy of Science and Distinguished Professor at the University of Electronic Science and Technology of China. Dr. Berlanga has made significant contributions to biomedical research and has been instrumental in various clinical trials and technical missions across multiple continents, earning recognition for his impactful work in regenerative medicine and pharmacology. His expertise is complemented by a strong commitment to education and mentorship in the scientific community. 🌟

Profile

Google Scholar

Strengths for the Award

  1. Extensive Education and Training: Dr. Berlanga has a solid academic background with a Doctor of Veterinary Medicine and a Ph.D. in Pharmaceutical Sciences and Pharmacology. His post-doctoral fellowships at prestigious institutions like the University of Alberta and Imperial Cancer Research Fund highlight his commitment to advancing medical knowledge.
  2. Research Contributions: His extensive work on epidermal growth factor (EGF) and its applications in wound healing, particularly in diabetic foot ulcers, is groundbreaking. He has led numerous research projects and has a substantial number of publications in reputable journals, indicating his active engagement in critical biomedical research.
  3. Recognition and Awards: Dr. Berlanga has received numerous prestigious awards, including the “Héroe del Trabajo de la República de Cuba” and various international recognitions, showcasing his impact and contributions to the field.
  4. Leadership in Scientific Community: His roles in coordinating research commissions, leading projects, and serving as a speaker at over 40 international conferences illustrate his leadership and influence in the scientific community.
  5. Multidisciplinary Approach: His research spans various aspects of pharmacology, tissue repair, and regenerative medicine, demonstrating his ability to integrate knowledge across disciplines effectively.
  6. International Collaboration: Dr. Berlanga’s involvement in international workshops and conferences shows his commitment to collaboration and the dissemination of knowledge globally.

Areas for Improvement

  1. Broader Research Scope: While Dr. Berlanga’s focus on EGF is significant, exploring additional areas of research could enhance his impact. Diversifying his research portfolio may lead to novel insights and applications in other fields of medicine.
  2. Public Engagement and Communication: Increasing his outreach efforts to communicate research findings to the general public could enhance the visibility of his work and its implications for healthcare.
  3. Mentorship Opportunities: Engaging more with younger researchers and students through mentorship programs could foster the next generation of scientists and broaden the research community’s perspectives.
  4. Interdisciplinary Collaboration: Further collaboration with other scientific disciplines, such as engineering or technology, could lead to innovative approaches in his research areas.

Education

Dr. Berlanga’s educational journey began with primary education in Bayamo, Granma, followed by secondary schooling. He obtained his Doctor of Veterinary Medicine from the Universidad de Granma in 1985. He furthered his studies with a PhD in Pharmaceutical Sciences and Pharmacology from the Universidad de La Habana in 2000. His academic pursuits included post-doctoral fellowships at renowned institutions, such as the University of Alberta in Canada and the Leicester General Hospital in the UK, focusing on wound healing and gastroenterology. Additionally, he completed numerous specialization courses in clinical pathology, molecular biology, and experimental pharmacology. His diverse educational background has equipped him with the knowledge and skills to advance biomedical research and contribute to the field significantly. 🎓

Experience

Dr. Berlanga’s professional experience includes roles as an instructor and assistant lecturer in Anatomical Pathology at the Universidad de Granma and as an Associate Professor of Pathology. He has been a researcher at the Centro de Ingeniería Genética y Biotecnología (CIGB) in Havana, focusing on EGF’s pharmacological effects and wound healing mechanisms. Over the years, he has led various departments and projects within CIGB, including preclinical studies and diabetic foot ulcer healing initiatives. His leadership has driven significant advancements in understanding tissue repair and regeneration. In addition to his research, Dr. Berlanga has been a prominent speaker at numerous international conferences, sharing his findings and fostering collaboration in the scientific community. His extensive experience has established him as a leading figure in the field of biomedical sciences. 🔬

Awards and Honors

Dr. Berlanga’s contributions to science have earned him numerous accolades. He received the Alberta Heritage Foundation Scholarship in 1995 and the Royal Society Annual Award in 1998. In 2011, he was honored with the Distinción Carlos J. Finlay and recognized by the World Intellectual Property Organization as the best young inventor. His achievements include being named Hijo Ilustre de Granma and Bayamo, as well as receiving the prestigious title of Héroe del Trabajo de la República de Cuba in 2020. He has also been acknowledged as a Distinguished Professor at the University of Electronic Science and Technology of China. These awards highlight his significant impact on science and society through innovative research and dedication to education. 🏆

Research Focus

Dr. Berlanga’s research primarily focuses on the pharmacological applications of Epidermal Growth Factor (EGF) in wound healing and tissue regeneration. His investigations have led to the development of various animal models to study EGF’s effects on diabetic foot ulcers, ischemia/reperfusion injury, and gastrointestinal health. He explores the molecular mechanisms underlying EGF’s protective properties and its role in enhancing healing processes. His work also includes studying cellular pathologic memory and its implications in diabetes and wound chronicity. Dr. Berlanga’s commitment to advancing regenerative medicine continues to shape therapeutic strategies for complex wound healing challenges, making significant contributions to biomedical science. 🧬

Publication Top Notes

  • Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis
  • The pro‐inflammatory environment in recalcitrant diabetic foot wounds
  • Intra‐lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo …
  • Epidermal growth factor in clinical practice–a review of its biological actions, clinical indications and safety implications
  • Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure
  • Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
  • Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing
  • Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds
  • Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome
  • Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats
  • Diabetic lower extremity wounds: the rationale for growth factors‐based infiltration treatment
  • Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction
  • Cellular senescence as the pathogenic hub of diabetes-related wound chronicity
  • Wound chronicity, impaired immunity and infection in diabetic patients
  • Insulin resistance at the crossroad of Alzheimer disease pathology: A review
  • Potency and stability of C terminal truncated human epidermal growth factor
  • Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds
  • Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) as tissue healing agents: clarifying concerns about their possible role in malignant transformation and …
  • Intestinal growth in parenterally‐fed rats induced by the combined effects of glucagon‐like peptide 2 and epidermal growth factor
  • Medical practice confirms clinical trial results of the use of intralesional human recombinant epidermal growth factor in advanced diabetic foot ulcers

Conclusion

Dr. Jorge Amador Berlanga Acosta exemplifies the qualities of an outstanding researcher through his extensive educational background, significant contributions to science, and recognized leadership. His innovative work on EGF and wound healing positions him as a strong candidate for the Best Researcher Award. By broadening his research scope, enhancing public engagement, and fostering mentorship, he can further elevate his impact on the scientific community and society at large.